NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1051 coverAUTOIMMUNE DISEASES AND TREATMENT: Organ-Specific and Systemic Disorders Volume 1051 published June 2005
Ann. N.Y. Acad. Sci. 1051: 787–798 (2005). doi: 10.1196/annals.1361.122
Copyright © 2005 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by TLASKALOVÁ-HOGENOVÁ, H.
Articles by BLAND, P.
Search for Related Content
PubMed
PubMed Citation
Articles by TLASKALOVÁ-HOGENOVÁ, H.
Articles by BLAND, P.
Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases

HELENA TLASKALOVÁ-HOGENOVÁa, LUDMILA TUCKOVÁa, RENATA STEPÁNKOVÁa, TOMÁS HUDCOVICa, LENKA PALOVÁ-JELÍNKOVÁa, HANA KOZÁKOVÁa, PAVEL ROSSMANNa, DANIEL SANCHEZa, JANA CINOVÁa, TOMÁS HRNCÍRa, MILOSLAV KVERKAa, LENKA FROLOVÁa, HOLM UHLIGb, FIONA POWRIEb AND PAUL BLANDc

aDepartment of Immunology and Gnotobiology, Institute of Microbiology, Academy of Sciences of the Czech Republic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
bUniversity of Oxford, Oxford, United Kingdom
cUniversity of Goteborg, Goteborg, Sweden

Address for correspondence: Prof. Helena Tlaskalová-Hogenová, M.D., Ph.D., Institute of Microbiology, Academy of Sciences of the Czech Republic, Department of Immunology and Gnotobiology, Víde-ská 1083, Prague 4, Czech Republic. Voice: +420-2-4106-2363; fax: +420-2-4172-1143. tlaskalo{at}biomed.cas.cz

Initial events and effector mechanisms of most inflammatory and autoimmune diseases remain largely unknown. Dysfunction of the innate and adaptive immune systems associated with mucosae (the major interface between the organism and its environment, e.g., microbiota, food) can conceivably cause impairment of mucosal barrier function and development of localized or systemic inflammatory and autoimmune processes. Animal models help in elucidating the etiology and pathogenetic mechanisms of human diseases, such as the inflammatory bowel diseases, Crohn's disease and ulcerative colitis, severe chronic diseases affecting the gut. To study the role of innate immunity and gut microbiota in intestinal inflammation, colitis was induced by dextran sulfate sodium (DSS) in mice with severe combined immunodeficiency (SCID). Conventionally reared (microflora-colonized) SCID mice displayed severe inflammation like that seen in immunocompetent Balb/c mice, whereas only minor changes appeared in the intestinal mucosa of DSS-fed gnotobiotic germ-free SCID mice. The presence of microflora facilitates the inflammation in DSS-induced colitis that develops in immunodeficient SCID mice, that is, in the absence of T and B lymphocytes. Celiac disease, a chronic autoimmune small bowel disorder, afflicts genetically susceptible individuals with wheat gluten intolerance. We showed that, in contrast with any other food proteins, wheat gliadin and its peptic fragments activate mouse macrophages and human monocytes to produce proinflammatory cytokines through the nuclear factor-{kappa}B signaling pathway. Activation of innate immunity cells by food proteins or components from gut microbiota thus could participate in the impairment of intestinal mucosa and the development of intestinal and/or systemic inflammation.

Key Words: innate immunity • mucosal immunity • mucosal barrier • inflammation • autoimmunity • animal models • germ-free animals • commensal bacteria • gut microbiota • inflammatory bowel diseases • celiac disease • gluten • gliadin




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
L. Frolova, P. Drastich, P. Rossmann, K. Klimesova, and H. Tlaskalova-Hogenova
Expression of Toll-like Receptor 2 (TLR2), TLR4, and CD14 in Biopsy Samples of Patients With Inflammatory Bowel Diseases: Upregulated Expression of TLR2 in Terminal Ileum of Patients With Ulcerative Colitis
J. Histochem. Cytochem., March 1, 2008; 56(3): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. E. Berndt, M. Zhang, G.-H. Chen, G. B. Huffnagle, and J. Y. Kao
The Role of Dendritic Cells in the Development of Acute Dextran Sulfate Sodium Colitis
J. Immunol., November 1, 2007; 179(9): 6255 - 6262.
[Abstract] [Full Text] [PDF]



footerLeft footerRight